Boston Medical Center Ped. HIV Program NICHD CRS

Boston, Massachusetts 02118

0 studies enrolling now · 14 studies all time

What they study most

H1N1 Influenza Virus, HIV, HIV Infection, HIV Infections, Meningitis, Respiratory Syncytial Virus Infections, Sexually Transmitted Diseases

Studies at this site

• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission — Recruiting now
• Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy — Completed
• Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents — Completed
• Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age — Completed
• Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants — Completed
• Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection — Completed
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth — Completed
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children — Completed
• Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women — Completed
• Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents — Completed
• A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines — Completed
• Optimizing Treatment for Treatment-Experienced, HIV-Infected People — Completed
• Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth — Completed
• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents — Completed